Perioperative Immune Modulation Shapes Surgical Recovery : J Cardiothorac Vasc Anesth | May 2026

Introduction

Surgery induces a complex inflammatory and immunologic response involving cytokine activation, neuroendocrine stress signaling and tissue repair pathways. While controlled inflammation is necessary for healing, excessive perioperative immune dysregulation contributes substantially to postoperative morbidity.

Problem Statement

The perioperative impact of anesthetic techniques on immune function, inflammation and long-term postoperative outcomes remains underrecognized despite growing evidence linking anesthetic modulation to recovery trajectories and organ dysfunction.

Summary

This review comprehensively examines how anesthetic strategies influence the perioperative immune response and subsequently affect postoperative recovery and complications.

The authors emphasize that surgical trauma activates systemic inflammatory cascades intended to facilitate tissue repair and host defense. However, exaggerated or poorly regulated inflammation can result in immune suppression, immune tolerance and multisystem organ dysfunction.

A major focus of the review is the immunomodulatory role of anesthetic agents themselves. Commonly used general anesthetics such as Propofol and volatile inhalational agents exert direct effects on cytokine signaling, leukocyte activity and inflammatory pathways.

The review highlights the dualistic nature of anesthetic immunomodulation. Appropriate suppression of excessive inflammation may reduce tissue injury and postoperative complications, whereas excessive immunosuppression may impair host defense, increase infection risk and potentially influence oncologic outcomes.

Regional anesthesia is discussed as a potentially more immune-preserving strategy compared with general anesthesia. By attenuating neuroendocrine stress responses and reducing systemic opioid requirements, regional techniques may limit perioperative immune disruption.

The article also reinforces the increasingly recognized relationship between perioperative inflammation and postoperative outcomes. Excessive inflammatory activation is associated with higher rates of postoperative pain, infection, cardiac complications, acute kidney injury, delayed mobilization and prolonged hospitalization.

Importantly, the review positions perioperative immune management as a modifiable therapeutic target rather than merely a physiologic consequence of surgery.

Several practical perioperative strategies are discussed, including optimization of anesthetic depth, individualized anesthetic selection, opioid-sparing approaches, anti-inflammatory therapies, nutritional support and immunomodulatory interventions.

The authors also explore emerging translational areas including immune checkpoint modulation and targeted immunotherapeutic strategies within perioperative medicine, although these remain largely investigational.

Clinically, the review aligns with the broader evolution of perioperative medicine toward precision anesthesiology and enhanced recovery paradigms. Modern perioperative care increasingly emphasizes physiologic optimization rather than simply intraoperative sedation and analgesia.

The work is particularly relevant in high-risk populations including elderly patients, cancer surgery populations, critically ill surgical patients and those with baseline immune dysfunction.

From an oncologic perspective, perioperative immune modulation may be especially important because surgical stress and immunosuppression can theoretically influence residual tumor biology, metastatic progression and antitumor immune surveillance.

The review also underscores the importance of multidisciplinary perioperative management involving anesthesiologists, surgeons, intensivists, nutrition teams and rehabilitation specialists to optimize inflammatory and immune recovery.

Importantly, the authors acknowledge that current evidence remains heterogeneous, with many mechanistic findings derived from experimental or translational studies rather than definitive clinical outcome trials.

Future research will likely focus on biomarker-guided perioperative immune profiling, individualized anesthetic immunophenotyping and targeted anti-inflammatory strategies integrated into enhanced recovery pathways.

Overall, this review highlights perioperative inflammation and immune regulation as central determinants of surgical recovery, emphasizing that anesthetic choice and perioperative immune modulation may substantially influence postoperative complications, organ dysfunction and long-term outcomes.